Cannabis Rescheduling: Page 2

Where Are We on Cannabis Rescheduling? It’s Been Months Since the US Attorney General’s April 2026 Order

There’s been no transparency about the applications of those seeking DEA registration. The IRS/Treasury has provided no guidance about what to do regarding §280E on those federal tax returns – even though, in April, the feds promised it would be forthcoming.

Federal Court Denies Anti-Rescheduling Parties’ Motion to Stay Schedule III Cannabis Order

The U.S. Court of Appeals for the District of Columbia Circuit won’t halt the Trump administration’s order that reclassified medical cannabis.

Will Judge’s Rescheduling Decision Be Influenced by Lone Opposed Party Witness DEA Did Not Discredit?

Some legal experts believe a pharmacologist’s testimony on currently accepted medical use could be the most damning for the Schedule III proposal.

DEA’s Final Schedule III Case Leads CBT’s Top Stories in August

The Drug Enforcement Administration tried to discredit nearly all opposing witnesses who testified during the rescheduling hearing in its post-hearing brief.

DEA Judge Releases Transcripts for Cannabis Rescheduling Hearing

With the fully corrected transcripts now part of the public record, the judge who oversaw the hearing’s proceedings now must make a recommendation.

DEA Judge Orders 294 Corrections to 2,500-Page Cannabis Hearing Transcript

The DEA’s administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.

US House Members Push Trump Administration for Guidance on Schedule III Federal Framework

A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.

DEA Makes Final Schedule III Case, Tries to Discredit Nearly All Opposing Witnesses

The government’s final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition’s ‘so-called experts.’

Georgia Cannabis Regulators Propose Allowing USPS Deliveries Under Rescheduling

The state’s 45,000-plus medical cannabis patients could receive dispensary products through federal or private mail carriers under the proposed rule change.

What to Expect From the DEA’s Cannabis Rescheduling Hearing Transcripts, Final Briefs

A law judge’s recommendation may not come down to whether anti-rescheduling parties proved a Schedule I listing, but whether they disproved the government’s Schedule III evidence.

Idaho’s Cannabis Legalization Campaign Effort Leads CBT’s Top Stories in July

Activists submitted signatures to the state secretary at the beginning of the month, after collecting more than double the required number for their petition.

DOJ Head Sidesteps Questions on Schedule III Order, Adult-Use Cannabis

Todd Blanche, Trump’s nominee to be the U.S. attorney general, answered questions for the record about his stances on rescheduling, 280E and enforcement.

Previous Page

Page 2 of 22

Next Page